These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The pathogenesis of chronic obstructive pulmonary disease, steroid resistance and the place of theophylline in the treatment].
    Author: Bayram H.
    Journal: Tuberk Toraks; 2009; 57(1):115-24. PubMed ID: 19533448.
    Abstract:
    Chronic obstructive pulmonary disease (COPD) is associated with airway obstruction, which is not fully reversible. It results from an abnormal inflammatory response of lungs to inhaled noxious agents and gases. There is a complex inflammation involving proximal and peripheral airways, lung parenchyma and pulmonary vascular structures in COPD. The inflammation is resistant to steroids, and it is believed that there may be a defect in the anti-inflammatory effects of these drugs in COPD. Recent studies reported an association between steroid resistance and decreased histone deacetylase (HDAC)-2 activity in lung cells of COPD patients. More recently, laboratory studies suggest that theophylline, at low doses, may reverse steroid resistance by enhancing decreased HDAC-2 activity. However, these findings need to be tested and confirmed in detailed clinical studies prior to implementation to clinical practice.
    [Abstract] [Full Text] [Related] [New Search]